SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
'Urgent National Action to Save College Sports': Trump’s NIL Playbook — Highway to NIL Podcast
March Madness or Trademark Madness? The NCAA v. DraftKings Lawsuit
Protecting Your Products and Brand Online
Lemon Pound Cake and the First Amendment
Episode 402: Paul Allen: The Promise of AI, Governance and Public Trust
Michele Moresco on the Transformational Potential of Photonics
Subject Matter Eligibility Challenges in Post-Grant Proceedings — Patents: Post-Grant Podcast
The Briefing: Vampires, Love Triangles, but No Infringement
Non-Competes in 2026: FTC Signals Major Policy Shift - Employment Law This Week® - Spilling Secrets Podcast
When Does a Beat Make You a Co-Writer? — No Infringement Intended Podcast
The Briefing: The Sound of a Lawsuit – David Greene vs Google NotebookLM
JONES DAY PRESENTS®: Trade Secret Litigation 10 Years After Enactment of the Defend Trade Secrets Act
JONES DAY TALKS®: Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions Remain
The Briefing: No Paper, No Standing: Kanye West, Copyright Transfers, and the Writing Requirement
The Briefing: Skechers, TikTok, and Khaby Lame: Is Barrett Wissman Potentially Liable?
The LathamTECH Podcast — Trade Secrets: The New Litigation Battleground
Podcast: Williams Mullen's Trending Now - An IP Podcast - When AI Meets Art: Litigation and Settlement Trends Affecting Artists
The Briefing: Vetter v. Resnik: When Copyright Termination Goes Global
IP Goes Pop! S7 Ep 1- We’re #1! Intellectual Property Firsts
Organizations that still believe well-worn myths concerning copyrighted materials do so to their own peril. Di’Vennci K. Lucas and Michael D. Hobbs Jr. of Troutman Pepper Locke break down several copyright-related fallacies...more
This case was filed in 2018 when Alvogen submitted to the FDA an ANDA for approval to market generic Belbuca, a buprenorphine buccal film used to administer the drug transmucosally....more
On March 30, 2026, Teva announced that the FDA and the European Medicines Agency (EMA) accepted regulatory submissions for its proposed biosimilar to Xolair® (omalizumab), TEV-45779....more
Online marketplaces create enormous opportunities for businesses to attract more customers and sell in previously unreachable markets. But the ecommerce landscape also makes it easier for counterfeit goods and unauthorized...more
Recent reports regarding the cancellation of Disney’s $1 billion investment in OpenAI offer a timely case study for understanding the unique features, advantages, and complexities associated with strategic minority equity...more
In an important decision, the Full Federal Court in The NOCO Company v Brown and Watson International held that the relevant date for assessing the best method known to the applicants is the filing date of each divisional...more
Last week, the Supreme Court vacated a copyright infringement judgment against an ISP provider and remanded the case to the Fifth Circuit for reconsideration in light of the Cox Communications decision (Grande Comm’s Networks...more
On March 30, 2026, the FDA approved Teva’s biosimilar Ponlimsi™ (denosumab-adet), referencing Amgen’s Prolia® (denosumab), for all indications of the reference product....more
On April 2, 2026, Biocon filed a petition for post-grant review (“PGR”) challenging Regeneron’s U.S. Patent No. 12,168,036 (“the ’036 patent”), which is directed to methods for treating angiogenic eye disorders using high...more
The United States Court of Appeals for the Federal Circuit has recently reinforced the consequences of prosecution history disclaimer. In Puradigm, LLC v. DBG Group Investments LLC, the court held that statements made during...more
The Federal Circuit reaffirmed the importance of accurate inventorship and maintaining access to inventors after patenting in Fortress Iron, LP, v. Digger Specialties, Inc., finding two patents invalid for incorrect...more
The General Services Administration (GSA) Federal Acquisition Service has released draft contract terms and conditions related to artificial intelligence (AI)-related procurements through a new proposed GSAR clause...more
Yesterday, President Trump signed the Small Business Innovation and Economic Security Act (the Act) into law. This concludes a more than six month lapse in the Small Business Innovation Research and Small Business Technology...more
This week marks an important new chapter in the self-regulation of advertising in the United States. Yesterday, the Center for Industry Self-Regulation's Institute for Responsible Influence (IRI) announced the launch of a new...more
Welcome to our Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies around the...more
The US Patent and Trademark Office (USPTO) has introduced a new pilot program that will require certain patent applicants to make an affirmative decision about whether to proceed with examination of their applications. The...more
Welcome to the SBR-Author’s Podcast! In this podcast series, Host Tom Fox visits with authors in the compliance arena and beyond. In this episode, Tom Fox welcomes Severin Wirz, Senior Director for Ethics and Compliance at...more
The Pitch newsletter is a monthly update of legal issues and news affecting or related to the music, film and television, fine arts, media, professional athletics, eSports, and gaming industries. The Pitch features a diverse...more
The UPC has been reshaping European patent litigation since its launch in June 2023. More than 480 patents have now been litigated in the court, and the number of actions is steadily increasing. Initially, major...more
Pharmaceutical research and development is becoming more expensive and taking longer. Innovative AI scale-ups and platforms are addressing this by quickly accumulating vast datasets, but the larger companies that buy them...more
Thanks to its scientific skills base, growing prowess in AI and a policy environment that supports rapid clinical trials, China has become one of the world’s leading markets for pharmaceutical innovation. Here we explore how...more
The woman known as the "Ketamine Queen" of North Hollywood was sentenced to 15 years in prison by a CA federal judge for several drug dealing-related crimes, including her role in providing the ketamine that led to the 2023...more
In the rapidly evolving landscape of technology, the innovations of today often become tomorrow's legal battlegrounds. In virtually every emerging technology there are startups and new players at every corner. In the...more
I recently spoke with a founder who had obtained a patent but wasn’t happy with it. Not because the patent was invalid. Not because the attorney made mistakes. But because the patent included a feature that made it easy for...more
Many readers will be familiar with the viral kid’s song “Baby Shark,” with its catchy, sing-along refrain. In an unexpected legal crossover, the tune recently surfaced in a Second Circuit case about the use of email to serve...more